Clinical and Molecular Hepatology (Apr 2024)

Letter: Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide fumarate in patients with chronic hepatitis B: More questions than an answer – author’s reply

  • Hyeyeon Hong,
  • Jonggi Choi

DOI
https://doi.org/10.3350/cmh.2024.0123
Journal volume & issue
Vol. 30, no. 2
pp. 272 – 273

Abstract

Read online

No abstracts available.

Keywords